Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Goldin

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
ERJ Open Research|February 4, 2025
Biological correlates of radiological features of systemic sclerosis interstitial lung diseaseElizabeth R Volkmann, Donald P Tashkin, Mei Leng, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 3, 2007
Accuracy of PET/CT in characterization of solitary pulmonary lesionsShanna K Kim, Martin Allen-Auerbach, Jonathan Goldin, et al.
Respiratory Research|November 29, 2025
A composite endpoint for systemic sclerosis-associated interstitial lung disease: association with mortality in two clinical trial cohortsElizabeth R Volkmann, Holly Wilhalme, Sam Good, et al.
Respirology (Carlton, Vic.)|February 9, 2010
Thoracic imagingDavid M Hansell, Phillip M Boiselle, Jonathan Goldin, et al.
The European Respiratory Journal|July 13, 2013
Target lobe volume reduction and COPD outcome measures after endobronchial valve therapyArschang Valipour, Felix J F Herth, Otto C Burghuber, et al.
Arthritis Care & Research|October 14, 2025
ReplyKristofer Andréasson, Jennifer S Labus, Arissa Young, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 4, 2021
Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung DiseaseDavid Roofeh, Celia J F Lin, Jonathan Goldin, et al.
ACR Open Rheumatology|August 18, 2023
Combining Clinical and Biological Data to Predict Progressive Pulmonary Fibrosis in Patients With Systemic Sclerosis Despite Immunomodulatory TherapyElizabeth R Volkmann, Holly Wilhalme, Shervin Assassi, et al.
Medical Physics|August 19, 2021
Ventilation measurements using fast-helical free-breathing computed tomographyDaniel A Low, Dylan O'Connell, Michael Lauria, et al.
Journal of Scleroderma and Related Disorders|May 19, 2022
The disconnect between visual assessment of air trapping and lung physiology for assessment of small airway disease in scleroderma-related interstitial lung disease: An observation from the Scleroderma Lung Study II CohortSangmee Sharon Bae, Lila Pourzand, Grace Hyun Kim, et al.
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
ERJ Open Research|February 4, 2025
Biological correlates of radiological features of systemic sclerosis interstitial lung diseaseElizabeth R Volkmann, Donald P Tashkin, Mei Leng, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 3, 2007
Accuracy of PET/CT in characterization of solitary pulmonary lesionsShanna K Kim, Martin Allen-Auerbach, Jonathan Goldin, et al.
Respiratory Research|November 29, 2025
A composite endpoint for systemic sclerosis-associated interstitial lung disease: association with mortality in two clinical trial cohortsElizabeth R Volkmann, Holly Wilhalme, Sam Good, et al.
Respirology (Carlton, Vic.)|February 9, 2010
Thoracic imagingDavid M Hansell, Phillip M Boiselle, Jonathan Goldin, et al.
The European Respiratory Journal|July 13, 2013
Target lobe volume reduction and COPD outcome measures after endobronchial valve therapyArschang Valipour, Felix J F Herth, Otto C Burghuber, et al.
Arthritis Care & Research|October 14, 2025
ReplyKristofer Andréasson, Jennifer S Labus, Arissa Young, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 4, 2021
Tocilizumab Prevents Progression of Early Systemic Sclerosis-Associated Interstitial Lung DiseaseDavid Roofeh, Celia J F Lin, Jonathan Goldin, et al.
ACR Open Rheumatology|August 18, 2023
Combining Clinical and Biological Data to Predict Progressive Pulmonary Fibrosis in Patients With Systemic Sclerosis Despite Immunomodulatory TherapyElizabeth R Volkmann, Holly Wilhalme, Shervin Assassi, et al.
Medical Physics|August 19, 2021
Ventilation measurements using fast-helical free-breathing computed tomographyDaniel A Low, Dylan O'Connell, Michael Lauria, et al.
Journal of Scleroderma and Related Disorders|May 19, 2022
The disconnect between visual assessment of air trapping and lung physiology for assessment of small airway disease in scleroderma-related interstitial lung disease: An observation from the Scleroderma Lung Study II CohortSangmee Sharon Bae, Lila Pourzand, Grace Hyun Kim, et al.
Pageof 11